InvestorsHub Logo
Followers 68
Posts 5584
Boards Moderated 0
Alias Born 01/13/2012

Re: Steve43 post# 219821

Tuesday, 03/24/2020 10:58:43 AM

Tuesday, March 24, 2020 10:58:43 AM

Post# of 330443
Most smart investors and fund guys have completed their re-balancing from say 75%-25% to 90%-10% or better, to catch the upward momentum. Can you imagine how much cash is sitting watching for those buy points? Most haven't heard much about the Pinks, but an announcement by a major in the pain space, and BIEL, would provide hi-octane for BIEL, providing the current CEO undoes the horrific damage caused by the former CEO in areas of deal-making (not), BoD, governance and the absurd share structure.

I’ve combined a few thoughts, in review. Question now is will the current CEO clean up the outrageous share structure and become the heroic darling of the corporate pharma/pain space before deals are announced, so the stock can fly to the sustainable levels it deserves? The sustained success of BIEL for all shareholders will best be achieved by getting all the ducks in a row at the right time and share structure is the key one.

The Whelans need to 'disappear' 28 billion of their 35 billion shares or so, reduce their holdings to 7 billion, protect the Corp from hostility by aligning with 'friends' and make a ton of money when deals are announced. 35 billion shares at $.0009 is the same as 7 billion at $.0045, so, if 'disappearing' a lot of the stock IBEX received as a result of churning the revolver financing model allows the stock to climb, farther than otherwise, to a sustainable spot in pennyland, versus not, then just get it done! Remaining in the toilet bowl versus sustainable pennyland!

No question, in my mind, that BIEL could be a guiding light out of the cauldron of CV despair if the share structure is fixed and a turnaround announced at the same time as one or more deals with majors. Announce the steps taken. Announce an expanded BoD. Such announcements and a broader distribution of news of ActiPatch, FDA cleared, USPTO patented, drug-free, side-effect free miniaturized pain remediation device? Bye bye toilets! Stock soars!!!

If she doesn't fix the absurd share structure, caused by the former CEO, before any announcement of a deal, then BIEL will not run as high or have the sp sustainability, as if she had fixed it. That will be her legacy, too little or ne at all, too late. The history of BIEL.